Melodiol Global Health (formerly Creso Pharma) was a Perth-based ASX-listed company that developed cannabis, hemp-derived and other plant based therapeutic, nutraceutical, and lifestyle products.
The company was delisted from the ASX in October 2024.
|
NEWS: Tagged in Board Moves December 1, 2022 | 01 Dec 2022 |
|
NEW ROLE: Peter Hatfull, Non-Executive Director | 01 Dec 2022 |
|
|
NEWS: Tagged in Board Moves November 17, 2022 | 17 Nov 2022 |
| Name | Position | Year Started | Year Ended |
|---|---|---|---|
Non-Executive Director, Chair since 2022
|
2015 | 2024 | |
Non-Executive Director
|
2022 | 2024 | |
Consultant
|
2017 | 2024 | |
Executive Director
|
2022 | 2024 | |
Non-Executive Director
|
2022 | 2024 | |
Executive Director
|
2022 | 2024 | |
Chief Operating Officer
|
2017 | 2024 | |
Non-Executive Director
|
2022 | 2024 | |
Chief Operating Officer, Americas
|
2018 | 2024 | |
Joint Company Secretary
|
2018 | 2024 | |
Joint Company Secretary
|
2018 | 2024 | |
International Business Development Executive
|
2018 | 2024 | |
Strategic Advisor
|
2021 | 2024 | |
Group Chief Executive & Managing Director
|
2022 | 2024 | |
Executive Vice President of Strategy, Originations & Operations
|
2021 | 2022 | |
Founder, Non-Executive Director, was Chair till 2021
|
2015 | 2022 | |
Executive Director, Interim Chair since 2021
|
2015 | 2022 | |
Non-Executive Director
|
2020 | 2021 | |
Co-Founder, Group Chief Executive, Executive Director, Head of Technology, Innovation & Distribution
|
2015 | 2020 | |
Company Secretary
|
2015 | 2018 | |
Non-Executive Director
|
2016 | 2017 | |
Non-Executive Director
|
2015 | ||
Chief Executive Officer, Managing Director
|
2023 | ||
Non-Executive Director
|
2018 | ||
Non-Executive Chairman, Non-Executive Director
|
2023 | ||
Non-Executive Director
|
2021 | ||
Chief Financial Officer
|
0 |
| Date | Company | Transaction Type | Total Value | |
|---|---|---|---|---|
| Melodiol Global Health | Placement | $2.50m | >> | |
| Melodiol Global Health | Placement | $2.00m | >> | |
| Melodiol Global Health | Placement | $7.00m | >> | |
| Melodiol Global Health | Placement | $5.00m | >> | |
| Melodiol Global Health | Placement | $18.68m | >> |
| Announced | Bidder | Target | Transaction Type | Total Value | |
|---|---|---|---|---|---|
| Melodiol Global Health | Health House International | Acquisition | $4.63m | >> | |
| Melodiol Global Health | Acquisition | $29.72m | >> | ||
| Melodiol Global Health | Reverse takeover | $211.00m | >> | ||
| Melodiol Global Health | Acquisition | $6.35m | >> | ||
| Melodiol Global Health | Acquisition | $122.00m | >> |
